These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 8439222)

  • 1. Oral anticoagulant therapy--50 years later.
    Ansell JE
    Arch Intern Med; 1993 Mar; 153(5):586-96. PubMed ID: 8439222
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oral anticoagulant therapy: practical considerations.
    Ansell JE; Holden A; Nozzolillo E
    Nurse Pract Forum; 1992 Jun; 3(2):105-13. PubMed ID: 1392666
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Present and future of oral anticoagulants].
    Meschengieser SS; Casais P; Sánchez Luceros A; Lazzari MA
    Medicina (B Aires); 2000; 60(1):139-42. PubMed ID: 10835711
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Survival of heparins, oral anticoagulants, and aspirin after the year 2010.
    Fareed J; Hoppensteadt DA; Fareed D; Demir M; Wahi R; Clarke M; Adiguzel C; Bick R
    Semin Thromb Hemost; 2008 Feb; 34(1):58-73. PubMed ID: 18393143
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [-Anticoagulant drugs-].
    Gulba DC
    Herz; 1996 Feb; 21(1):12-27. PubMed ID: 8647576
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Patient education and oral anticoagulant therapy.
    Barcellona D; Contu P; Marongiu F
    Haematologica; 2002 Oct; 87(10):1081-6. PubMed ID: 12368164
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of a portable prothrombin time monitor for home use by patients who require long-term oral anticoagulant therapy.
    Anderson DR; Harrison L; Hirsh J
    Arch Intern Med; 1993 Jun; 153(12):1441-7. PubMed ID: 8512435
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Anticoagulant prophylaxis: from clinical trials to clinical practice].
    Scardi S; Mazzone C
    G Ital Cardiol; 1998 Feb; 28(2):178-86. PubMed ID: 9534059
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Changing trends in anti-coagulant therapies. Are heparins and oral anti-coagulants challenged?
    Fareed J; Iqbal O; Cunanan J; Demir M; Wahi R; Clarke M; Adiguzel C; Bick R
    Int Angiol; 2008 Jun; 27(3):176-92. PubMed ID: 18506123
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Outpatient oral anticoagulant management--an audit of 82 patients.
    Kakkar N; Kaur R; John M
    J Assoc Physicians India; 2005 Oct; 53():847-52. PubMed ID: 16459526
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [A retrospective survey on practice of oral anticoagulant therapy in patients with cardiovascular diseases].
    Katona A; Márk L
    Orv Hetil; 2004 Aug; 145(32):1643-7. PubMed ID: 15384862
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Oral anticoagulants in cardiac patients undergoing elective surgical procedures: what attitude to adopt?].
    Yerly P; Schapira M; Vogt P
    Rev Med Suisse; 2005 May; 1(21):1412-4, 1416-7. PubMed ID: 15997979
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oral anticoagulation therapy: indications, contraindications, and complications.
    Donhou GE
    Nurse Pract Forum; 1992 Jun; 3(2):86-94. PubMed ID: 1392676
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Management of oral anticoagulant treatment in patients with venous thromboembolism.
    Pengo V
    Semin Thromb Hemost; 2006 Nov; 32(8):781-6. PubMed ID: 17171590
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The efficacy and safety of perioperative low molecular weight heparin substitution in patients on chronic oral anticoagulant therapy undergoing transurethral prostatectomy for bladder outlet obstruction.
    Dotan ZA; Mor Y; Leibovitch I; Varon D; Golomb J; Duvdevani M; Ramon J
    J Urol; 2002 Aug; 168(2):610-3; discussion 614. PubMed ID: 12131319
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ximelagatran: a new oral anticoagulant.
    Hrebickova L; Nawarskas JJ; Anderson JR
    Heart Dis; 2003; 5(6):397-408. PubMed ID: 14633322
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outpatient management of oral vitamin K antagonist therapy: defining and measuring high-quality management.
    Phillips KW; Ansell J
    Expert Rev Cardiovasc Ther; 2008 Jan; 6(1):57-70. PubMed ID: 18095907
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bleeding risk of combined oral anticoagulant and antiplatelet therapy in cardiovascular disease.
    Verheugt FW
    J Cardiovasc Risk; 1996 Apr; 3(2):229-32. PubMed ID: 8836868
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationship between international normalized ratio values, vitamin K-dependent clotting factor levels and in vivo prothrombin activation during the early and steady phases of oral anticoagulant treatment.
    D'Angelo A; Della Valle P; Crippa L; Fattorini A; Pattarini E; Viganò D'Angelo S
    Haematologica; 2002 Oct; 87(10):1074-80. PubMed ID: 12368163
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Pharmacokinetic aspects of overdosage and intoxication with oral anticoagulant drugs (author's transl)].
    Jähnchen E; Meinertz T
    Arzneimittelforschung; 1977; 27(96):1849-56. PubMed ID: 303522
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.